A
Alcolase
Denmark · Biotech · Healthtech · Consumer
Alcolase is developing a liposomal enzyme system intended to break down alcohol in the stomach before absorption.
Product and customers
The Copenhagen biotech protects enzymes inside liposomes so they can remain active in stomach conditions. Its initial application targets alcohol intolerance associated with ALDH2 deficiency. The product remains under development, with initial target markets in Singapore and South Korea.
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Undisclosed | €1.5M | Ada Ventures — Role not disclosedAntler — Role not disclosedDelphinus Venture Capital — Role not disclosedManigoff Invest — Role not disclosed |